Levels of CC16 are demonstrated to correlate with disease activity of ILD in systemic sclerosis, and SP-D has shown to be useful to diagnose and predict risk of exacerbation and mortality in idiopathic pulmonary fibrosis [38, 39]. Here, SFTPD is linked to systemic sclerosis.